Dr.Reddy's Laboratories reports 11% rise in Q3 consolidated net profit

31 Jan 2024 Evaluate

Dr. Reddy's Laboratories has reported results for third quarter ended December 31, 2023 (Q3FY24). 

The company has reported 46.40% rise in net profit at Rs 475.20 crore for the third quarter ended December 31, 2023 as compared to Rs 324.60 crore for the same quarter in the previous year. Total income of the company increased by 9.66% at Rs 4330.60 crore for Q3FY24 as compared Rs 3949.00 crore for corresponding quarter of the previous year.

On consolidated basis, the company reported 11.01% rise in its net profit at Rs 1380.90 crore for Q3FY24 as compared to Rs 1243.90 crore for the same quarter in the previous year. Total income of the company increased by 8.83% at Rs 7453.00 crore for Q3FY24 as compared Rs 6848.50 crore for corresponding quarter of the previous year.

Dr. Reddys Lab Share Price

1220.00 25.45 (2.13%)
22-Nov-2024 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.00
Dr. Reddys Lab 1220.00
Cipla 1495.35
Lupin 2071.15
Zydus Lifesciences 950.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.